Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 143

Results For "pharma"

4738 News Found

International Society of Pharmacovigilance opens South Asia chapter
Public Health | November 16, 2021

International Society of Pharmacovigilance opens South Asia chapter

The aim is to support Pharmacovigilance programme across the countries in the region


Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
News | November 12, 2021

Natco Pharma PAT at Rs 65.1 cr. in Q2FY22

Natco Pharma has reported consolidated financial results for the period ended September 30, 2021


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.


J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
News | November 12, 2021

J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22

J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021


Sun Pharma to introduce molnupiravir in India
Drug Approval | November 12, 2021

Sun Pharma to introduce molnupiravir in India

The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India


Alembic Pharma PAT at Rs 169.29 cr. in Q2FY22
News | November 11, 2021

Alembic Pharma PAT at Rs 169.29 cr. in Q2FY22

The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.


Curadev Pharma partners with CMC Vellore for dengue research
Healthcare | November 11, 2021

Curadev Pharma partners with CMC Vellore for dengue research

The company will provide the technical and financial resources to support the study


Sudeep Pharma ventures into nutrition
Healthcare | November 11, 2021

Sudeep Pharma ventures into nutrition

Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers


AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22
News | November 10, 2021

AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22

The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021


Marksons Pharma PAT slips to Rs 46.28 in Q2FY22
News | November 10, 2021

Marksons Pharma PAT slips to Rs 46.28 in Q2FY22

Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021